“…Of the pharmacological agents susceptible to delirium, patients who used Midazolam, during their stay in intensive care units, developed changes in alertness, as predicted in the literature (Girard, Thompson, Pandharipande, Brummel, Jackson, 2018& Lago, Faustino, Merces, Silva, Pessoa, Oliveira, 2020& Haenggi et al, 2013& Cerveira, Pupo, Santos, 2017& Shinotsuka, Salluh, 2013& Nunes, Bastos, 2016& Patel, Grambell, Speroff, Scott, Pun, 2009& Burry et al, 2017& Gusmão-Flores, Carvalho, Quarantini, 2013& Riker et al, 2009& Shehabi et al, 2018, a baixas dosagens e poucos dias de uso, assim como previsto em estudos anteriores (Cerveira, Pupo, Santos, 2017& Patel, Grambell, Speroff, Scott, Pun, 2009& Riker et al, 2009& Shehabi et al, 2018, highlighting the influence of benzodiazepines in the process of capturing neurotransmitters via the Central Nervous System and its potential for sedation.…”